Patients’ ability to use a novel fluticasone propionate/formoterol breath-triggered inhaler (BTI) vs. budesonide/formoterol dry powder inhaler (DPI)
Sign Up to like & getrecommendations! Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2018.pa610
Abstract: Introduction: GINA guidelines recognise the importance of correct inhaler technique and patient preference when individualising therapy. A novel BTI (Flutiform® K‑haler®) has been developed to deliver fluticasone propionate/formoterol (FP/FORM). Aims and Objectives: To investigate correct… read more here.
Keywords: formoterol; form bti; bti; inhaler ... See more keywords